| First Author | Sacchetti C | Year | 2017 |
| Journal | Nat Commun | Volume | 8 |
| Issue | 1 | Pages | 1060 |
| PubMed ID | 29057934 | Mgi Jnum | J:254330 |
| Mgi Id | MGI:6100853 | Doi | 10.1038/s41467-017-01168-1 |
| Citation | Sacchetti C, et al. (2017) PTP4A1 promotes TGFbeta signaling and fibrosis in systemic sclerosis. Nat Commun 8(1):1060 |
| abstractText | Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and internal organs. Protein tyrosine phosphatases have received little attention in the study of SSc or fibrosis. Here, we show that the tyrosine phosphatase PTP4A1 is highly expressed in fibroblasts from patients with SSc. PTP4A1 and its close homolog PTP4A2 are critical promoters of TGFbeta signaling in primary dermal fibroblasts and of bleomycin-induced fibrosis in vivo. PTP4A1 promotes TGFbeta signaling in human fibroblasts through enhancement of ERK activity, which stimulates SMAD3 expression and nuclear translocation. Upstream from ERK, we show that PTP4A1 directly interacts with SRC and inhibits SRC basal activation independently of its phosphatase activity. Unexpectedly, PTP4A2 minimally interacts with SRC and does not promote the SRC-ERK-SMAD3 pathway. Thus, in addition to defining PTP4A1 as a molecule of interest for TGFbeta-dependent fibrosis, our study provides information regarding the functional specificity of different members of the PTP4A subclass of phosphatases. |
